{ "company": "Pacific Biosciences", "ticker": "PACB", "period": { "from": "2026-02-26", "to": "2026-03-28", "days": 30 }, "sentiment_breakdown": { "positive": 28, "negative": 16, "neutral": 49 }, "synthesis": { "executive_summary": "**Executive Summary: Pacific Biosciences (PACB) Sentiment Analysis**\n\nPacific Biosciences (PACB) exhibited a predominantly neutral sentiment during the period of February 26 to March 28, 2026, with 49 out of 93 analyzed items classified as neutral. However, a notable positive bias was observed, with 28 positive items outweighing 16 negative items. Key drivers of positive sentiment included multiple analyst upgrades to a 'Strong Buy' rating, primarily attributed to improving earnings outlooks and upward revisions in estimates. Strategic collaborations, such as the partnership with Basecamp Research for the Trillion Gene Atlas project, and the announcement of SMRT Grant winners, also contributed to a favorable perception of the company's technological advancements.\n\nThe most significant positive events centered on PACB's financial outlook, with multiple reports highlighting its upgrade to a Zacks Rank #1 (Strong Buy), signaling potential for market-beating returns due to improved earnings projections. This was further bolstered by the Basecamp Research agreement, expected to drive demand for PACB's HiFi sequencing technology. Conversely, the negative sentiment pool included several items irrelevant to PACB's core business. It is noteworthy that some company-specific news, despite detailing advancements in cancer research and HiFi technology, were classified with negative sentiment scores in the provided data. Overall, the period reflects strong analyst confidence and positive operational developments, alongside a significant neutral volume and some mixed negative signals.", "key_findings": [ "✓ Pacific Biosciences (PACB) upgraded to strong buy: What does it mean for the stock?", "✓ Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?", "✓ 2025 Immunology and Immunotherapy SMRT Grant winners announced", "✗ Old men harassing middle school girls and rage baiting in Pacific Highland Ranch today", "✗ Pacific Biosciences of California technology maps cancer structural variants in single platform advance", "✗ In 1943, Congressman Andrew J. May revealed to the press that U.S. submarines in the Pacific had a high survival rate because Japanese depth charges exploded at too shallow depth. At least 10 submarines and 800 crew were lost when the Japanese Navy modified the charges after the news reached Tokyo." ], "overall_sentiment": "positive" }, "top_positive": [ { "title": "Pacific Biosciences (PACB) upgraded to strong buy: What does it mean for the stock?", "date": "2026-03-19", "source": "alpha_vantage", "score": 0.711 }, { "title": "Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?", "date": "2026-03-18", "source": "alpha_vantage", "score": 0.711 }, { "title": "2025 Immunology and Immunotherapy SMRT Grant winners announced", "date": "2026-03-25", "source": "alpha_vantage", "score": 0.681 }, { "title": "PacBio Secures Agreement with Basecamp Research for Trillion Gene Atlas Project", "date": "2026-03-27", "source": "alpha_vantage", "score": 0.67 }, { "title": "Pacific Biosciences (PACB) Raised to Strong Buy: What Are the Implications for Its Shares?", "date": "2026-03-18", "source": "alpha_vantage", "score": 0.67 }, { "title": "A contender for try of the season in Super Rugby Pacific", "date": "2026-02-27", "source": "reddit", "score": 0.66 }, { "title": "Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine.", "date": "2026-03-28", "source": "pubmed", "score": 0.572 }, { "title": "Large equity grants to PacBio (PACB) executive highlight retention focus", "date": "2026-03-03", "source": "alpha_vantage", "score": 0.511 }, { "title": "Equity awards to Pacific Biosciences (PACB) officer disclosed", "date": "2026-03-03", "source": "alpha_vantage", "score": 0.459 }, { "title": "Pacific Biosciences (PACB) officer receives large option and RSU awards", "date": "2026-03-03", "source": "alpha_vantage", "score": 0.459 } ], "top_negative": [ { "title": "Old men harassing middle school girls and rage baiting in Pacific Highland Ranch today", "date": "2026-03-14", "source": "reddit", "score": -0.796 }, { "title": "Pacific Biosciences of California technology maps cancer structural variants in single platform advance", "date": "2026-03-12", "source": "alpha_vantage", "score": -0.66 }, { "title": "In 1943, Congressman Andrew J. May revealed to the press that U.S. submarines in the Pacific had a high survival rate because Japanese depth charges exploded at too shallow depth. At least 10 submarines and 800 crew were lost when the Japanese Navy modified the charges after the news reached Tokyo.", "date": "2026-03-05", "source": "reddit", "score": -0.625 }, { "title": "Pacific Biosciences of California expands cancer research with new epigenetics lesson in sequencing series", "date": "2026-03-20", "source": "alpha_vantage", "score": -0.612 }, { "title": "Pacific Biosciences of California introduces HiFi sequencing for comprehensive cancer analysis", "date": "2026-03-15", "source": "alpha_vantage", "score": -0.527 }, { "title": "Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates", "date": "2026-03-27", "source": "alpha_vantage", "score": -0.518 }, { "title": "TIL that Alaska Airlines worker John Liotine had his recommendation to replace an aging jackscrew on an MD-83 during routine maintenance overruled in 1997. On January 31st, 2000 the same MD-83, Alaska Airlines Flight 261 crashed mid flight over the Pacific Ocean due to the jackscrew failing.", "date": "2026-03-25", "source": "reddit", "score": -0.511 }, { "title": "Motorcycle engine powered drone to cross Asia and the fucking Pacific Ocean to attack us? False flag incoming.", "date": "2026-03-11", "source": "reddit", "score": -0.477 }, { "title": "Motorcycle engine powered drone to cross Asia and the fucking Pacific Ocean to attack us? False flag incoming.", "date": "2026-03-11", "source": "reddit", "score": -0.477 }, { "title": "Fucking weirdos outside Trader Joe’s Pacific Highlands Ranch", "date": "2026-03-14", "source": "reddit", "score": -0.338 } ], "raw_data": { "total_items": 93, "items": [ { "source": "alpha_vantage", "title": "Vanguard amendment shows 0 PACB shares after realignment (PACB)", "url": "https://www.stocktitan.net/sec-filings/PACB/schedule-13g-a-pacific-biosciences-of-california-inc-amended-passive--193c9cb0abec.html", "date": "2026-03-27", "summary": "The Vanguard Group filed an amendment to its Schedule 13G/A for Pacific Biosciences of California Inc (PACB), reporting 0 shares beneficially owned as of March 13, 2026. This change is due to an internal realignment effective January 12, 2026, where certain Vanguard subsidiaries will now report their beneficial ownership separately. The filing confirms that The Vanguard Group no longer holds beneficial ownership over these securities.", "sentiment_score": 0.021648, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates", "url": "https://www.msn.com/en-us/money/topstocks/pacific-biosciences-of-california-pacb-reports-q2-loss-beats-revenue-estimates/ar-AA1K7v8O?apiversion=v2&noservercache=1&domshim=1&renderwebcomponents=1&wcseo=1&batchservertelemetry=1&noservertelemetry=1", "date": "2026-03-27", "summary": "Pacific Biosciences of California (PACB) reported a narrower-than-expected loss in its Q2 earnings, with a loss of $0.30 per share which was better than the Zacks Consensus Estimate of a $0.33 loss. The company also surpassed revenue estimates, posting $38.35 million against an anticipated $37.07 million. Despite beating estimates, the revenue figure represents a slight year-over-year decline.", "sentiment_score": 0.292145, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.518, "confidence": 0.52 } }, { "source": "alpha_vantage", "title": "PacBio Secures Agreement with Basecamp Research for Trillion Gene Atlas Project", "url": "https://www.bitget.com/amp/news/detail/12560605307320", "date": "2026-03-27", "summary": "PacBio has partnered with Basecamp Research for the ambitious Trillion Gene Atlas project, utilizing its HiFi sequencing on the Revio platform to create the largest and most diverse high-fidelity metagenomic dataset. This collaboration aims to advance AI-powered drug discovery by providing comprehensive genomic information for Basecamp's EDEN platform, speeding up the creation of new therapies. The agreement is expected to drive demand for PacBio's technology and consumables, with the company cu", "sentiment_score": 0.497247, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.67, "confidence": 0.67 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California grants early SPRQ-Nx beta access to scientists for HiFi sequencing", "url": "https://tradersunion.com/news/companies/show/1795785-early-sprq-nx-chemistry/", "date": "2026-03-25", "summary": "Pacific Biosciences of California has given early beta access to its SPRQ-Nx sequencing chemistry to a select group of scientists, including Katy Munson from the University of Washington. This program allows experts to evaluate the new technology's workflow and economic benefits, which is designed to enhance high-fidelity sequencing. The company previously launched HiFi sequencing for cancer research and automatic epigenetic detection through HiFi sequencing runs.", "sentiment_score": 0.419384, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "alpha_vantage", "title": "2025 Immunology and Immunotherapy SMRT Grant winners announced", "url": "https://www.pacb.com/blog/2025-immunology-and-immunotherapy-smrt-grant-winners-announced/", "date": "2026-03-25", "summary": "PacBio and ClareoBio have announced the four winners of the 2025 PacBio Immunology and Immunotherapy SMRT Grant. The grant attracted hundreds of proposals from researchers globally, all aiming to use ClareoBio's ProfilAIR assay powered by PacBio HiFi sequencing for advanced immune profiling. The selected projects will explore B-cell receptor repertoires in Kawasaki disease, IgG subclass dynamics in Chronic Lymphocytic Leukemia, clonal dynamics in DLBCL patients undergoing CAR-T therapy, and mate", "sentiment_score": 0.402997, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.681, "confidence": 0.68 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California researcher uncovers genetic variants shaping brain disorders", "url": "https://tradersunion.com/news/companies/show/1775001-rare-ataxias-genetic-research/", "date": "2026-03-24", "summary": "Pacific Biosciences of California is exploring the genetic basis of rare ataxias to understand neurological function and disorders better. By focusing on small communities, the company's research aims to identify subtle genetic variants and population patterns to advance personalized medicine and neurological research. This initiative builds on their recent developments in HiFi sequencing technology for detailed cancer variation analysis and automatic epigenetic detection.", "sentiment_score": 0.63718, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California (PACB) dips more than broader market: What you should know", "url": "https://www.msn.com/en-us/money/topstocks/pacific-biosciences-of-california-pacb-dips-more-than-broader-market-what-you-should-know/ar-AA1Z4ZDJ", "date": "2026-03-21", "summary": "This article from MSN provides a concise financial update on Pacific Biosciences of California (PACB). It notes that PACB's stock underperformed the broader market, as indicated by its trading dip. Investors seeking quick summaries of market performance would find this information relevant.", "sentiment_score": -0.440843, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California (PACB) Falls Further Than the Overall Market: Key Information to Note", "url": "https://www.bitget.com/amp/news/detail/12560605287597", "date": "2026-03-20", "summary": "Pacific Biosciences of California (PACB) stock recently dropped 5% to $1.33, underperforming the broader market and the Medical sector over the past month. Investors are awaiting its next earnings report, where analysts project a loss of $0.17 per share and a revenue increase to $41 million. Despite recent declines, PACB currently holds a Zacks Rank of #2 (Buy), indicating potential for future outperformance within the Medical - Instruments industry.", "sentiment_score": -0.255685, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California expands cancer research with new epigenetics lesson in sequencing series", "url": "https://tradersunion.com/news/companies/show/1753675-cancer-epigenetics-video-launch/", "date": "2026-03-20", "summary": "Pacific Biosciences of California has launched a new epigenetics lesson as part of its Cancer Sequencing 101 series. This video explains how researchers can use HiFi sequencing data to analyze DNA methylation and chromatin accessibility for cancer discovery. The educational initiative aims to equip scientists and clinicians with essential knowledge to foster innovation in oncology research.", "sentiment_score": 0.450902, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.612, "confidence": 0.61 } }, { "source": "alpha_vantage", "title": "Cancer genomics myths revisited: How advances in HiFi sequencing keep strengthening the evidence", "url": "https://www.pacb.com/blog/cancer-genomics-myths-revisited-how-advances-in-hifi-sequencing-keep-strengthening-the-evidence/", "date": "2026-03-19", "summary": "This article debunks common misconceptions about long-read sequencing in cancer genomics, highlighting how HiFi sequencing advances are making it more affordable, compatible with FFPE samples, and effective for detecting complex transcriptomic dysregulation and somatic variants. It emphasizes the improving throughput and bioinformatics accessibility of HiFi sequencing, along with its increasing clinical utility in research.", "sentiment_score": 0.817108, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "DNA Sequencing Market size to hit $108.95 Billion by 2035 | Top", "url": "https://www.openpr.com/news/4431311/dna-sequencing-market-size-to-hit-108-95-billion-by-2035-top", "date": "2026-03-19", "summary": "The DNA Sequencing Market is projected to reach $108.95 billion by 2035, growing at a CAGR of 20.5% from its 2025 valuation of USD 16.88 billion. This growth is driven by advancements in Next-Generation Sequencing (NGS) technologies, increasing applications in precision medicine, and the integration of AI and bioinformatics. Key players like Illumina, Thermo Fisher Scientific, and Pacific Biosciences are innovating to expand their market presence.", "sentiment_score": 0.309186, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.943651, "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Canaccord reiterates Pacific Biosciences stock rating on new chemistry", "url": "https://m.investing.com/news/analyst-ratings/canaccord-reiterates-pacific-biosciences-stock-rating-on-new-chemistry-93CH-4570362?ampMode=1", "date": "2026-03-19", "summary": "Canaccord Genuity has reiterated a \"Buy\" rating and a $3.00 price target for Pacific Biosciences of California (NASDAQ:PACB), anticipating growth from its new SPRQ-Nx chemistry and reusable SMRT cells expected in late 2026. This technology aims to improve data yield and reduce costs, positioning the company for larger-scale sequencing applications despite near-term macro and funding challenges. However, the company faces financial headwinds, including a \"WEAK\" financial health score, and while r", "sentiment_score": 0.209975, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences (PACB) upgraded to strong buy: What does it mean for the stock?", "url": "https://www.msn.com/en-us/money/topstocks/pacific-biosciences-pacb-upgraded-to-strong-buy-what-does-it-mean-for-the-stock/ar-AA1YVtVN", "date": "2026-03-19", "summary": "This article announces that Pacific Biosciences (PACB) has been upgraded to a \"strong buy\" rating. It will likely discuss the implications of this upgrade for the company's stock performance. Investors and potential investors will be interested in understanding the factors driving this upgraded rating and its potential impact on PACB's market position.", "sentiment_score": 0.530525, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.711, "confidence": 0.71 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences (PACB) Raised to Strong Buy: What Are the Implications for Its Shares?", "url": "https://www.bitget.com/amp/news/detail/12560605277280", "date": "2026-03-18", "summary": "Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #1 (Strong Buy) due to positive shifts in its earnings outlook and improved earnings projections. This rating, based on objective earnings revisions, suggests a favorable earnings trajectory and potential for the stock's outperformance, as Zacks Rank #1 stocks have historically shown strong returns. The company is projected to report earnings of -$0.54 per share for fiscal year 2026, with recent analyst estimates for PACB increasing by", "sentiment_score": 0.46806, "sentiment_label": "Bullish", "relevance_score": 0.959811, "sentiment": { "label": "positive", "score": 0.67, "confidence": 0.67 } }, { "source": "alpha_vantage", "title": "Inside the trillion-gene atlas training AI to design new medicines", "url": "https://www.stocktitan.net/news/PACB/basecamp-research-selects-pac-bio-hi-fi-sequencing-to-power-trillion-yis4ufqu5cul.html", "date": "2026-03-18", "summary": "PacBio (NASDAQ: PACB) has announced a collaboration with Basecamp Research to power the Trillion Gene Atlas using PacBio HiFi sequencing on the Revio system with SPRQ-Nx chemistry. This initiative aims to generate approximately 100,000 deeply sequenced samples from 31 countries across 5 continents, creating the largest high-fidelity metagenomic dataset to date. The goal is to leverage this expansive and diverse data to train next-generation AI models for biological design and accelerate the deve", "sentiment_score": 0.416404, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?", "url": "https://finance.yahoo.com/news/pacific-biosciences-pacb-upgraded-strong-160004615.html", "date": "2026-03-18", "summary": "Pacific Biosciences of California (PACB) has been upgraded to a Zacks Rank #1 (Strong Buy) due to an upward trend in earnings estimates. The Zacks rating system highlights companies with improving earnings outlooks, which often correlate with near-term stock price movements. This upgrade places PACB in the top 5% of Zacks-covered stocks, suggesting potential for market-beating returns.", "sentiment_score": 0.428487, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.711, "confidence": 0.71 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California Q2 2025 Earnings Preview", "url": "http://www.msn.com/en-us/money/topstocks/pacific-biosciences-of-california-q2-2025-earnings-preview/ar-AA1K28i0?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "date": "2026-03-17", "summary": "This article provides a preview of Pacific Biosciences of California's Q2 2025 earnings. It likely discusses expectations for the company's financial performance in the upcoming quarter.", "sentiment_score": 0.00501, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California introduces HiFi sequencing for comprehensive cancer analysis", "url": "https://tradersunion.com/news/companies/show/1696581-pacbio-hifi-cancer-sequencing/", "date": "2026-03-15", "summary": "Pacific Biosciences of California is advancing cancer analysis with its HiFi sequencing technology, designed to detect a full range of cancer variations including structural variants, methylation patterns, RNA isoforms, and fusions. This single platform aims to provide comprehensive genomic insights, positioning PacBio as a key player in oncology research. The company has also emphasized its previous work on integrating automatic epigenetic detection within HiFi sequencing, further enhancing its", "sentiment_score": 0.475709, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.527, "confidence": 0.53 } }, { "source": "alpha_vantage", "title": "PACB,TAL Options", "url": "https://finviz.com/quote.ashx?t=PACB%2CTAL&ta=1&p=w&ty=oc&ov=list_date&e=2026-06-18", "date": "2026-03-13", "summary": "This article provides detailed financial and news information for Pacific Biosciences of California Inc (PACB) and TAL Education Group (TAL). It includes stock performance metrics, insider trading activities, analyst ratings, and recent news headlines for both companies, offering a comprehensive overview for potential investors.", "sentiment_score": 0.038784, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California technology maps cancer structural variants in single platform advance", "url": "https://tradersunion.com/news/companies/show/1682934-cancer-genomics-innovation/", "date": "2026-03-12", "summary": "Pacific Biosciences of California has unveiled new research showcasing its PacBio HiFi technology, which can map hundreds of structural variants, novel isoforms, and critical fusions in cancer genomics. This advanced platform aims to predict patient survival and guide treatment by providing comprehensive genetic insights through a single workflow. This innovation has the potential to significantly impact cancer research and clinical applications and builds upon earlier advancements in epigenetic", "sentiment_score": 0.846266, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "alpha_vantage", "title": "HiFi sequencing enables automatic detection of 5mC and 6mA, Pacific Biosciences of California asserts", "url": "https://tradersunion.com/news/companies/show/1652278-pacbio-hifi-epigenetics/", "date": "2026-03-09", "summary": "Pacific Biosciences of California has introduced its HiFi sequencing platform, which can automatically detect epigenetic modifications like 5-methylcytosine (5mC) and 6-methyladenine (6mA) in a single sequencing run. This technology uses kinetic signature analysis, eliminating the need for extra library preparation. The company highlights its efficiency for genomic researchers by providing simultaneous sequence and epigenetic information.", "sentiment_score": 0.441387, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "PACB Stock Price, Quote & Chart | PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB)", "url": "https://www.chartmill.com/stock/quote/PACB/profile", "date": "2026-03-09", "summary": "Pacific Biosciences of California (NASDAQ:PACB) currently trades at $1.33 USD, up 4.72% today, but has seen significant declines over longer periods. ChartMill assigns PACB a technical rating of 0/10 and a fundamental rating of 2/10, citing poor profitability and financial health. Analysts, however, forecast an average price target of $2.48, suggesting an 86.25% increase, with expected EPS growth of 71.86% and revenue growth of 10.42% in the next year.", "sentiment_score": -0.085471, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "AI biotech leader Chris Gibson joins PacBio (PACB) board of directors", "url": "https://www.stocktitan.net/sec-filings/PACB/8-k-pacific-biosciences-of-california-inc-reports-material-event-880a290d9db7.html", "date": "2026-03-08", "summary": "PacBio (NASDAQ: PACB) has appointed Christopher Gibson, Ph.D., co-founder and Chairman of Recursion, to its Board of Directors as a Class I director, effective March 3, 2026. This appointment expands the board to ten members, with Dr. Gibson also serving on the Science and Technology Committee. His expertise in leveraging AI, automation, and high-dimensional biological data for drug discovery aligns with PacBio's strategic vision of integrating HiFi long-read sequencing with advanced analytics t", "sentiment_score": 0.428877, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "[Form 4] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Insider Trading Activity", "url": "https://www.stocktitan.net/sec-filings/PACB/form-4-pacific-biosciences-of-california-inc-insider-trading-activity-90b49df2323a.html", "date": "2026-03-07", "summary": "PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) director Christopher Gibson reported equity awards stemming from his election to the Board on March 3, 2026. He received stock options for 73,087 shares and a grant of 53,913 restricted stock units (RSUs). These awards, not open-market purchases, vest over several years contingent on his continued service as a director, with the first vesting dates in March 2027.", "sentiment_score": 0.117714, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Patent deal locks in protections for Pacific Biosciences (NASDAQ: PACB) with PGI", "url": "https://www.stocktitan.net/sec-filings/PACB/8-k-pacific-biosciences-of-california-inc-reports-material-event-d5718c68f987.html", "date": "2026-03-07", "summary": "Pacific Biosciences (NASDAQ: PACB) has settled a patent dispute with Personal Genomics of Taiwan, Inc. (PGI), securing a worldwide, royalty-free, non-exclusive license and a five-and-a-half-year covenant not to sue from PGI. In exchange, PacBio will make fixed payments totaling $8 million in Q1 2026 and $5 million in Q1 2027, 2028, and 2029, with potential increases to the 2027 payment based on 2026 revenue. Additionally, Pacific Biosciences announced the voluntary resignation of its Chief Accou", "sentiment_score": 0.246044, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.998158, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "PACB - Pacific Biosciences of California Inc Stock Price and Quote", "url": "https://finviz.com/quote.ashx?t=PACB", "date": "2026-03-07", "summary": "The article provides a detailed overview of Pacific Biosciences of California Inc (PACB) stock, including its latest trading information, financial metrics, and recent news. It highlights the company's stock performance, insider transactions, and a list of analyst ratings, alongside recent operational and financial announcements.", "sentiment_score": -0.344919, "sentiment_label": "Somewhat-Bearish", "relevance_score": 0.995043, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "PacBio Announces the Appointment of Chris Gibson to the Board of Directors", "url": "https://www.sahmcapital.com/news/content/pacbio-announces-the-appointment-of-chris-gibson-to-the-board-of-directors-2026-03-05", "date": "2026-03-07", "summary": "PacBio has appointed Christopher Gibson, Ph.D., co-founder and Chairman of Recursion, to its Board of Directors. Dr. Gibson's expertise in leveraging AI, automation, and high-dimensional biological data for scientific discovery is expected to strengthen PacBio's efforts in integrating sequencing, computation, and data-driven discovery to maximize the power of HiFi sequencing. This strategic move aims to accelerate understanding and treatment of complex diseases by combining advanced sequencing t", "sentiment_score": 0.449864, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences announces accounting officer transition and litigation settlement", "url": "https://m.investing.com/news/sec-filings/pacific-biosciences-announces-accounting-officer-transition-and-litigation-settlement-93CH-4547838?ampMode=1", "date": "2026-03-07", "summary": "Pacific Biosciences of California (NASDAQ:PACB) announced that Chief Accounting Officer Michele Farmer will resign on March 21, with CFO Jim R. Gibson assuming her responsibilities. The company also settled litigation with Personal Genomics of Taiwan through a licensing agreement and a payment schedule totaling at least $18 million. These developments follow recent news of better-than-expected Q4 2025 financial results but a stock downgrade by Barclays, and the appointment of Christopher Gibson ", "sentiment_score": 0.034761, "sentiment_label": "Neutral", "relevance_score": 0.344779, "sentiment": { "label": "negative", "score": -0.202, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know", "url": "https://finviz.com/news/332761/pacbio-conmed-moderna-quidelortho-and-tandem-diabetes-shares-are-falling-what-you-need-to-know", "date": "2026-03-06", "summary": "Shares of PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes fell after a February jobs report indicated an unexpected contraction in employment, particularly in the healthcare sector. This news raised investor concerns about a potential economic slowdown and reduced healthcare spending. The article also touches on PacBio's stock volatility, recent dips due to inflation concerns, and its significant year-to-date decline.", "sentiment_score": -0.612581, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "PACB Analyst Rating Downgrade by Barclays to Underweight | PACB Stock News", "url": "https://www.gurufocus.com/news/8685527/pacb-analyst-rating-downgrade-by-barclays-to-underweight-pacb-stock-news", "date": "2026-03-06", "summary": "Barclays has downgraded Pacific Biosciences (PACB) from an Equal-Weight to an Underweight rating, simultaneously reducing its price target by 25% from $2.00 to $1.50. This adjustment follows several rating changes from other analysts in late 2025, which primarily maintained neutral or overweight ratings with various price targets. Despite the downgrade, the average one-year price target from 7 analysts suggests a potential upside of 59.77% from the current price, and the brokerage firm consensus", "sentiment_score": -0.409061, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Barclays downgrades Pacific Biosciences stock rating on catalysts", "url": "https://m.investing.com/news/analyst-ratings/barclays-downgrades-pacific-biosciences-stock-rating-on-catalysts-93CH-4546604?ampMode=1", "date": "2026-03-06", "summary": "Barclays downgraded Pacific Biosciences of California (NASDAQ:PACB) from Equalweight to Underweight, setting a price target of $1.50 due to a lack of meaningful near-term upside despite acknowledging the company's technology and management. The firm highlighted concerns about Pacific Biosciences' rapid cash burn, significant debt, and the illiquidity of its stock, forecasting underperformance relative to its peers. This downgrade comes despite recent positive financial results and a new board ap", "sentiment_score": -0.410122, "sentiment_label": "Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "PacBio Appoints New Board Member", "url": "https://intellectia.ai/news/stock/pacbio-appoints-new-board-member", "date": "2026-03-06", "summary": "PacBio has appointed Dr. Christopher Gibson, co-founder of Recursion, to its Board of Directors, leveraging his expertise in AI-driven drug discovery to enhance its genomic strategies. Dr. Gibson's experience in integrating large-scale biological data with machine learning aligns with PacBio's goals for data-driven discovery and accelerating clinical development. This appointment is expected to strengthen PacBio's market competitiveness and accelerate healthcare discoveries through AI analytics ", "sentiment_score": 0.333222, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Beyond the Bench: Exploring the terrain of repeat expansion diseases with HiFi sequencing", "url": "https://www.pacb.com/blog/beyond-the-bench-exploring-the-terrain-of-repeat-expansion-diseases-with-hifi-sequencing/", "date": "2026-03-05", "summary": "This article highlights Dr. Birgitt Schuele's research on repeat expansion diseases, particularly Spinocerebellar Ataxia Type 10 (SCA10), using PacBio's HiFi sequencing technology. It explains how HiFi sequencing overcomes the limitations of short-read methods by providing long, accurate reads to precisely characterize complex repeat regions, which is crucial for understanding and developing treatments for these neurological disorders. The article emphasizes the blend of personal passion and tec", "sentiment_score": 0.443894, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacbio announces the appointment of Chris Gibson to the board of directors", "url": "https://www.marketscreener.com/news/pacbio-announces-the-appointment-of-chris-gibson-to-the-board-of-directors-ce7e5fdbdb8ffe24", "date": "2026-03-05", "summary": "Pacbio (Pacific Biosciences of California, Inc.) has announced the appointment of Christopher Gibson to its Board of Directors, effective March 3, 2026. Gibson will also serve as a member of the Science and Technology Committee. This move aims to strengthen the company's governance and strategic direction.", "sentiment_score": 0.431847, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "AI drug discovery founder from Recursion joins PacBio board", "url": "https://www.stocktitan.net/news/PACB/pac-bio-announces-the-appointment-of-chris-gibson-to-the-board-of-lw9ja56bt7pr.html", "date": "2026-03-05", "summary": "PacBio (NASDAQ: PACB) has appointed Christopher Gibson, Ph.D., co-founder and Chairman of Recursion (NASDAQ: RXRX), to its Board of Directors. Dr. Gibson's expertise in AI-driven drug discovery and building high-dimensional biology platforms is expected to strengthen PacBio's capabilities in developing data tools and advanced analytics for its HiFi long-read sequencing technology. This strategic move aims to integrate sequencing, computation, and data-driven discovery to accelerate scientific in", "sentiment_score": 0.480643, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 12,497 Shares", "url": "https://www.marketbeat.com/instant-alerts/pacific-biosciences-of-california-nasdaqpacb-insider-christian-henry-sells-12497-shares-2026-03-04/", "date": "2026-03-05", "summary": "Christian Henry, an insider at Pacific Biosciences of California (NASDAQ:PACB), sold 12,497 shares of the company's stock for approximately $18,870 on March 3rd. Following this sale, Henry still owns over 3.5 million shares. Despite being unprofitable, analysts have a \"Moderate Buy\" consensus rating for PACB with a target price of $2.20.", "sentiment_score": -0.074838, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "PRISM 2026 set to shape genomics future, Pacific Biosciences of California asserts", "url": "https://tradersunion.com/news/companies/show/1618063-pacific-biosciences-prism-innovation/", "date": "2026-03-04", "summary": "Pacific Biosciences of California (PacBio) has announced \"PRISM 2026,\" an upcoming event designed to showcase the latest advancements in its HiFi sequencing technology. The event aims to bring together researchers and industry experts to explore how this technology is currently influencing study design and supporting large-scale genomic analyses, positioning PRISM 2026 as a crucial platform for innovation in genomics.", "sentiment_score": 0.442214, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB)", "url": "https://finviz.com/news/329146/life-sciences-tools-services-stocks-q4-recap-benchmarking-pacbio-nasdaq-pacb", "date": "2026-03-04", "summary": "This article benchmarks PacBio (NASDAQ:PACB) and its peers in the life sciences tools and services sector after their Q4 earnings reports. It highlights PacBio's strong revenue performance, exceeding expectations, while noting the stock's subsequent decline. The article also reviews Q4 results for Illumina (NASDAQ:ILMN), Fortrea (NASDAQ:FTRE), Azenta (NASDAQ:AZTA), and West Pharmaceutical Services (NYSE:WST), providing a sector overview and outlook.", "sentiment_score": -0.209385, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Tax-withholding share sale by PacBio (NASDAQ: PACB) officer", "url": "https://www.stocktitan.net/sec-filings/PACB/form-4-pacific-biosciences-of-california-inc-insider-trading-activity-f5ccd31bae46.html", "date": "2026-03-04", "summary": "Christian O. Henry, an officer at Pacific Biosciences of California, Inc. (PACB), reported an open-market sale of 12,497 shares of common stock at a weighted average price of $1.514 per share. This sale was conducted to cover tax withholding obligations associated with vested restricted stock units, not as a discretionary sale. Following this transaction, Henry directly holds 3,581,813 shares of PACB common stock.", "sentiment_score": 0.000205, "sentiment_label": "Neutral", "relevance_score": 0.303397, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Large equity grants to PacBio (PACB) executive highlight retention focus", "url": "https://www.stocktitan.net/sec-filings/PACB/form-4-pacific-biosciences-of-california-inc-insider-trading-activity-a555154addfe.html", "date": "2026-03-03", "summary": "PacBio officer Christian O. Henry received substantial equity-based compensation, including stock options for 1,841,621 shares and restricted stock units (RSUs) for 920,810 shares, both granted at a $0.00 exercise price. These awards are geared towards retention, with multi-year vesting schedules contingent on his continued service to the company. This compensation package ties a significant portion of his future wealth to the company's long-term performance and ensures his ongoing commitment.", "sentiment_score": 0.051291, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "alpha_vantage", "title": "Equity awards to Pacific Biosciences (PACB) officer disclosed", "url": "https://www.stocktitan.net/sec-filings/PACB/form-4-pacific-biosciences-of-california-inc-insider-trading-activity-c075e0e4f891.html", "date": "2026-03-03", "summary": "Pacific Biosciences of California, Inc. (PACB) disclosed that officer Michele Farmer received new equity awards, including a stock option for 179,670 shares and an award of 89,835 Restricted Stock Units (RSUs). These awards, granted on February 27, 2026, vest over several years and are contingent on Farmer's continued service to the company. Following these transactions, Michele Farmer's direct ownership of PACB common stock totals 308,927 shares.", "sentiment_score": 0.148335, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences (PACB) officer receives large option and RSU awards", "url": "https://www.stocktitan.net/sec-filings/PACB/form-4-pacific-biosciences-of-california-inc-insider-trading-activity-f3ed40652c71.html", "date": "2026-03-03", "summary": "Pacific Biosciences (PACB) officer Mark Van Oene received significant equity awards, including a stock option for 1,000,000 shares and 500,000 Restricted Stock Units (RSUs). These awards, granted at an exercise price of $0.00 per share, are contingent on his continued service to the company. The RSUs will vest in three equal annual installments starting in 2027, while the stock options will vest in 36 equal monthly installments beginning in March 2026.", "sentiment_score": 0.034489, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "alpha_vantage", "title": "PacBio and DNAstack Join Forces to Launch Worldwide HiFi Genome Network Hub", "url": "https://www.bitget.com/amp/news/detail/12560605235008", "date": "2026-03-03", "summary": "PacBio and DNAstack have partnered to launch the first-ever worldwide federated dataset for HiFi whole genome sequencing data, called the HiFi Solves Global Consortium. This initiative allows scientists to securely access and analyze harmonized genomic information from institutions globally without centralizing sensitive patient data, which is crucial for accelerating rare disease research. The collaboration aims to expand the impact of PacBio’s HiFi sequencing technology and ensure its long-ter", "sentiment_score": 0.474334, "sentiment_label": "Bullish", "relevance_score": 0.981864, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "PacBio and DNAstack Join Forces to Launch Worldwide HiFi Genome Network Hub", "url": "https://www.bitget.com/news/detail/12560605235008", "date": "2026-03-03", "summary": "PacBio and DNAstack have partnered to launch the first global federated dataset of HiFi whole genome sequencing data through the HiFi Solves Global Consortium. This initiative enables secure access and analysis of harmonized genomic information from institutions worldwide, without centralizing sensitive patient data, accelerating rare disease research while upholding privacy. The collaboration aims to expand the impact of PacBio's HiFi sequencing technology and integrate it into international re", "sentiment_score": 0.491392, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California enables automatic epigenetic data in HiFi sequencing runs", "url": "https://tradersunion.com/news/companies/show/1602400-epigenetic-sequencing-hifi-launch/", "date": "2026-03-02", "summary": "Pacific Biosciences of California has announced that its HiFi sequencing technology will now automatically include epigenetic data, such as 5mC and 6mA modifications, during sequencing runs. This advancement streamlines workflows for researchers by integrating genetic and epigenetic insights into a single process. HiFi sequencing is known for its high accuracy in producing long reads of native DNA.", "sentiment_score": 0.416659, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California backs San Diego event to strengthen rare disease awareness", "url": "https://tradersunion.com/news/companies/show/1588569-pacific-biosciences-rare-disease/", "date": "2026-03-01", "summary": "Pacific Biosciences of California is sponsoring San Diego’s Rare Disease Day event to advance research and awareness for rare diseases. The company is collaborating with families, healthcare providers, researchers, and advocates to highlight patient stories and scientific progress. This sponsorship aims to bring attention to the challenges faced by the rare disease community and encourage continued scientific engagement.", "sentiment_score": 0.538608, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "alpha_vantage", "title": "PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know", "url": "https://finviz.com/news/325752/pacbio-myriad-genetics-lemaitre-hims-hers-health-and-goodrx-shares-are-falling-what-you-need-to-know", "date": "2026-02-27", "summary": "Shares of PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx fell following a hotter-than-expected wholesale inflation report, which increased investor concerns about persistent price pressures and potential impacts on future interest rate decisions. The Producer Price Index (PPI) surged, suggesting inflation may be more entrenched than anticipated. Notably, GoodRx experienced significant volatility and is down considerably since the beginning of the year.", "sentiment_score": -0.306011, "sentiment_label": "Somewhat-Bearish", "relevance_score": 0.961623, "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California joins IRDiRC to advance rare disease research", "url": "https://tradersunion.com/news/companies/show/1581109-pacbio-joins-irdirc/", "date": "2026-02-27", "summary": "Pacific Biosciences of California has become a member of the International Rare Diseases Research Consortium (IRDiRC). This partnership aims to accelerate rare disease research by promoting equitable genomic discovery and fostering collaboration among global stakeholders. The move highlights Pacific Biosciences' commitment to scientific advancement and making a positive impact on patients.", "sentiment_score": 0.435284, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Vestmark Advisory Solutions Inc. Sells 692,663 Shares of Pacific Biosciences of California, Inc. $PACB", "url": "https://www.marketbeat.com/instant-alerts/filing-vestmark-advisory-solutions-inc-sells-692663-shares-of-pacific-biosciences-of-california-inc-pacb-2026-02-27/", "date": "2026-02-27", "summary": "Vestmark Advisory Solutions Inc. significantly reduced its stake in Pacific Biosciences of California (NASDAQ:PACB) by selling 692,663 shares, cutting its ownership by 53.5% to 601,523 shares valued at approximately $770,000. Insiders also sold a substantial number of shares, totaling 707,731 shares worth $1.13 million, with notable sales from Michele Farmer and Christian O. Henry. Despite insider selling, analysts maintain a \"Moderate Buy\" rating with a consensus price target of $2.20, and the ", "sentiment_score": 0.136118, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.44, "confidence": 0.44 } }, { "source": "alpha_vantage", "title": "Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of \"Moderate Buy\" from Analysts", "url": "https://www.marketbeat.com/instant-alerts/pacific-biosciences-of-california-inc-nasdaqpacb-receives-average-rating-of-moderate-buy-from-analysts-2026-02-27/", "date": "2026-02-27", "summary": "Pacific Biosciences of California, Inc. (NASDAQ:PACB) has received an average \"Moderate Buy\" rating from analysts, with a target price of $2.20. Key points include significant insider selling totaling over 700,000 shares, while institutional investors like ARK Investment Management have increased their stakes. The company recently beat Q4 EPS estimates, though revenue was in line with expectations.", "sentiment_score": 0.18991, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-03-06", "url": "https://www.sec.gov/Archives/edgar/data/1299130/000129913026000053/0001299130-26-000053-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-03-05", "url": "https://www.sec.gov/Archives/edgar/data/1299130/000129913026000046/0001299130-26-000046-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41879279", "title": "A genome assembly of the North American golden eagle, Aquila chrysaetos canadensis.", "authors": "Capel SLR et al.", "journal": "The Journal of heredity", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41879279/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41867848", "title": "Molecular Transducers of Physical Activity Consortium (MoTrPAC): Initial Insights into the Dynamic Human Responses to Exercise.", "authors": "MoTrPAC Study Group et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 5", "url": "https://pubmed.ncbi.nlm.nih.gov/41867848/", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "pubmed", "pmid": "41849659", "title": "Chromosome-Scale Genome Assembly and Characterization of Saccharomycopsis schoenii, a Necrotrophic Predatory Yeast.", "authors": "Kriti D et al.", "journal": "G3 (Bethesda, Md.)", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41849659/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41847002", "title": "Evaluating genome assemblies with HMM-Flagger.", "authors": "Asri M et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41847002/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41811444", "title": "SypC, a symbiont outer membrane vesicle protein, impacts the development of the squid-vibrio partnership.", "authors": "Kuwabara JT et al.", "journal": "Proceedings of the National Academy of Sciences of the United States of America", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41811444/", "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "pubmed", "pmid": "41807732", "title": "HiFi long-read RNA sequencing enhances clinical diagnostics in rare disorders.", "authors": "Jaramillo Oquendo C et al.", "journal": "European journal of human genetics : EJHG", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41807732/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41796418", "title": "Mycorrhizal specialization for Tulasnellaceae fungi in Taeniophyllum marianense, a leafless epiphytic orchid native to Guam.", "authors": "Fernandez MAP et al.", "journal": "Journal of plant research", "date": "2026 Mar 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41796418/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41795468", "title": "Identification of de novo variants from parent-proband duos via long-read sequencing.", "authors": "Boukas L et al.", "journal": "American journal of human genetics", "date": "2026 Mar 5", "url": "https://pubmed.ncbi.nlm.nih.gov/41795468/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41780767", "title": "Comparison of single-cell sequencing technologies for allele-specific expression analysis in rabbit spermatids.", "authors": "Smertina E et al.", "journal": "Genomics", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41780767/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41764538", "title": "Decoding exon inclusion in the human brain reveals more divergent splicing mechanisms in neurons than glia.", "authors": "Michielsen L et al.", "journal": "Genome biology", "date": "2026 Feb 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41764538/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41672886", "title": "Assessing the readiness of Oxford Nanopore sequencing for clinical genomics applications.", "authors": "Arres J et al.", "journal": "Genome research", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41672886/", "sentiment": { "label": "positive", "score": 0.25, "confidence": 0.25 } }, { "source": "pubmed", "pmid": "41604583", "title": "A Murine Database of Structural Variants Identifies A Candidate Gene for a Spontaneous Murine Lymphoma Model.", "authors": "Ren W et al.", "journal": "Advanced science (Weinheim, Baden-Wurttemberg, Germany)", "date": "2026-03-28", "url": "https://pubmed.ncbi.nlm.nih.gov/41604583/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41539721", "title": "Read-level genotyping of short tandem repeats using long reads and single-nucleotide variation with STRkit.", "authors": "Lougheed DR et al.", "journal": "Genome research", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41539721/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41420489", "title": "Equity-focused implementation to enhance access to rare disease genomic research and understand diverse perspectives.", "authors": "Martinez E et al.", "journal": "Genetics in medicine : official journal of the American College of Medical Genetics", "date": "2026-03-28", "url": "https://pubmed.ncbi.nlm.nih.gov/41420489/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "40890511", "title": "Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine.", "authors": "Glazer AM et al.", "journal": "Nature reviews. Cardiology", "date": "2026-03-28", "url": "https://pubmed.ncbi.nlm.nih.gov/40890511/", "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "pubmed", "pmid": "40741976", "title": "Genome resources-A chromosome-level genome assembly for the long-nosed leopard lizard, Gambelia wislizenii, the first reference genome for the lizard family Crotaphytidae.", "authors": "McGuire JA et al.", "journal": "The Journal of heredity", "date": "2026 Mar 5", "url": "https://pubmed.ncbi.nlm.nih.gov/40741976/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "edgar_news", "title": "Pacific Biosciences Of California, Inc.", "text": "Michele Farmer resigns as Chief Accounting Officer, effective March 21, 2026, and Jim R. Gibson will assume the role. Also, the Company entered a term sheet with Personal Genomics of Taiwan, Inc., including a license, covenant not to sue, and $23M in payments.\n\n*Pacific Biosciences Of California, Inc. [PACB](https://www.google.com/finance/quote/PACB:NASDAQ) is headquartered in Menlo Park, CA.*\n\n[Source](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000053/pacb-20260302.htm)", "author": "edgar_news_01", "score": 1, "num_comments": 0, "date": "2026-03-06", "url": "https://reddit.com/r/edgar_news/comments/1rmqxqu/pacific_biosciences_of_california_inc/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "edgar_news", "title": "Pacific Biosciences Of California, Inc.", "text": "PacBio welcomes Dr. Christopher Gibson, co-founder of Recursion, to its Board. His expertise in AI-driven drug discovery will boost PacBio's development of data tools to maximize HiFi sequencing. This collaboration aims to enhance biological insights.\n\n*Pacific Biosciences Of California, Inc. [PACB](https://www.google.com/finance/quote/PACB:NASDAQ) is headquartered in Menlo Park, CA.*\n\n[Source](https://www.sec.gov/Archives/edgar/data/1299130/000129913026000046/pacb-ex991xchrisgibsonboar.htm)", "author": "edgar_news_01", "score": 1, "num_comments": 0, "date": "2026-03-05", "url": "https://reddit.com/r/edgar_news/comments/1rlj5r9/pacific_biosciences_of_california_inc/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "todayilearned", "title": "TIL that Alaska Airlines worker John Liotine had his recommendation to replace an aging jackscrew on an MD-83 during routine maintenance overruled in 1997. On January 31st, 2000 the same MD-83, Alaska Airlines Flight 261 crashed mid flight over the Pacific Ocean due to the jackscrew failing.", "text": "", "author": "Next_Worth_3616", "score": 20353, "num_comments": 576, "date": "2026-03-25", "url": "https://reddit.com/r/todayilearned/comments/1s3bfr6/til_that_alaska_airlines_worker_john_liotine_had/", "sentiment": { "label": "negative", "score": -0.511, "confidence": 0.51 } }, { "source": "reddit", "subreddit": "sandiego", "title": "Old men harassing middle school girls and rage baiting in Pacific Highland Ranch today", "text": "Does anybody know who these clowns are? They were apparently harassing middle school girls after school in Pacific Highland Ranch today and rage baiting people. ", "author": "Defiant_Rice8364", "score": 2724, "num_comments": 953, "date": "2026-03-14", "url": "https://reddit.com/r/sandiego/comments/1rt49fg/old_men_harassing_middle_school_girls_and_rage/", "sentiment": { "label": "negative", "score": -0.796, "confidence": 0.8 } }, { "source": "reddit", "subreddit": "sandiego", "title": "Fucking weirdos outside Trader Joe’s Pacific Highlands Ranch", "text": "This was 40 min ago not sure if they’re still there or not. I don’t know how these people can live with themselves ruining so many people’s days and getting off on it.\n\nI was a bit shaken up after this because I was parked right in front of Trader Joe’s and I walked out with my baby in the stroller and at first I didn’t know what was going on. Then I realized they were harassing anybody that paid them attention. Unfortunately, the lady parked right next to me was telling them not to record her s", "author": "natalerose24", "score": 2090, "num_comments": 1130, "date": "2026-03-14", "url": "https://reddit.com/r/sandiego/comments/1rt5yft/fucking_weirdos_outside_trader_joes_pacific/", "sentiment": { "label": "negative", "score": -0.338, "confidence": 0.34 } }, { "source": "reddit", "subreddit": "dancehall", "title": "Meanwhile in pacific islands", "text": "", "author": "Guniguggu", "score": 10936, "num_comments": 177, "date": "2026-03-06", "url": "https://reddit.com/r/dancehall/comments/1rmdb4f/meanwhile_in_pacific_islands/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "interestingasfuq", "title": "A seal swims through the lineup and casually climbs onto a surfer’s board for a short rest - Pacific Beach, San Diego.", "text": "", "author": "Kronyzx", "score": 4048, "num_comments": 303, "date": "2026-03-04", "url": "https://reddit.com/r/interestingasfuq/comments/1rkhw72/a_seal_swims_through_the_lineup_and_casually/", "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "reddit", "subreddit": "HistoricalCapsule", "title": "In 1943, Congressman Andrew J. May revealed to the press that U.S. submarines in the Pacific had a high survival rate because Japanese depth charges exploded at too shallow depth. At least 10 submarines and 800 crew were lost when the Japanese Navy modified the charges after the news reached Tokyo.", "text": "", "author": "zadraaa", "score": 6232, "num_comments": 205, "date": "2026-03-05", "url": "https://reddit.com/r/HistoricalCapsule/comments/1rljm3o/in_1943_congressman_andrew_j_may_revealed_to_the/", "sentiment": { "label": "negative", "score": -0.625, "confidence": 0.62 } }, { "source": "reddit", "subreddit": "HebelnMitKopf", "title": "ARKK vom 13.03.26 --- viele kleine Verkäufe ---", "text": "", "author": "Superb-Neck-5160", "score": 8, "num_comments": 0, "date": "2026-03-16", "url": "https://reddit.com/r/HebelnMitKopf/comments/1rv3bk9/arkk_vom_130326_viele_kleine_verkäufe/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "trains", "title": "Union Pacific unveiled their America 250 units today", "text": "ET44AC #4547 will be a tribute to U.S. President Trump, and 1776 will wear America 250 logos on the nose", "author": "Sharman19", "score": 2350, "num_comments": 388, "date": "2026-03-21", "url": "https://reddit.com/r/trains/comments/1rzcv92/union_pacific_unveiled_their_america_250_units/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "interestingasfuck", "title": "To power the journey, a satellite-tagged bar-tailed godwit builds massive fat reserves before departure and even shrink some internal organs during flight to reduce weight and energy use,an extreme adaptation for long distance migration across the Pacific.", "text": "", "author": "Low-Psychology-288", "score": 7290, "num_comments": 170, "date": "2026-03-08", "url": "https://reddit.com/r/interestingasfuck/comments/1rnvjry/to_power_the_journey_a_satellitetagged_bartailed/", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "reddit", "subreddit": "hockey", "title": "[Jason Gregor] “We are lucky to be in the division this year. All the teams are. It is a pillow fight right now,” McDavid on the Pacific.", "text": "https://xcancel.com/jasongregor/status/2035580197786046659?s=46", "author": "sykeseve", "score": 2615, "num_comments": 235, "date": "2026-03-22", "url": "https://reddit.com/r/hockey/comments/1s0d6tt/jason_gregor_we_are_lucky_to_be_in_the_division/", "sentiment": { "label": "positive", "score": 0.052, "confidence": 0.05 } }, { "source": "reddit", "subreddit": "trains", "title": "Union Pacific, you have let us down.", "text": "Their commemorative unit is literally just a regular locomotive with a teeny weeny 250th sticker slapped on the nose. Its like BNSF infected Union Pacific.\n\nI'd be willing to forgive it though, if it weren't for the disgrace that is 4547. The paint scheme actually looks really good, but the paint is ruined by the fact its commemorating *Trump* of all people. \n\nI don't want to go down a political rabbit hole, so I'm setting personal feelings aside and judging this locomotive based on what it is. ", "author": "Ornery_Feature_3466", "score": 1985, "num_comments": 292, "date": "2026-03-22", "url": "https://reddit.com/r/trains/comments/1s0bkqj/union_pacific_you_have_let_us_down/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "BeAmazed", "title": "A Pacific wren surfing on a leaf", "text": "", "author": "Necessary-Win-8730", "score": 18911, "num_comments": 73, "date": "2026-03-26", "url": "https://reddit.com/r/BeAmazed/comments/1s42jze/a_pacific_wren_surfing_on_a_leaf/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "HistoricalCapsule", "title": "Japanese-Americans at an internment camp in the Pacific Northwest (early 1940s)", "text": "", "author": "bncout", "score": 1118, "num_comments": 428, "date": "2026-03-15", "url": "https://reddit.com/r/HistoricalCapsule/comments/1ruj1ax/japaneseamericans_at_an_internment_camp_in_the/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "sandiego", "title": "Motorcycle engine powered drone to cross Asia and the fucking Pacific Ocean to attack us? False flag incoming.", "text": "2027 gonna have Trump did 9/11 2.0 memes 🥀", "author": "Organic_Fee_8502", "score": 1108, "num_comments": 369, "date": "2026-03-11", "url": "https://reddit.com/r/sandiego/comments/1rr37ge/motorcycle_engine_powered_drone_to_cross_asia_and/", "sentiment": { "label": "negative", "score": -0.477, "confidence": 0.48 } }, { "source": "reddit", "subreddit": "geography", "title": "Why do both the southern and northern pacific coasts of the americas have this kind of fractured, archipelago-like coastline? is there any relationship or is it just a coincidence?", "text": "", "author": "Spirited_Visit7597", "score": 2122, "num_comments": 178, "date": "2026-03-06", "url": "https://reddit.com/r/geography/comments/1rmh1vm/why_do_both_the_southern_and_northern_pacific/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "AlternateHistoryHub", "title": "What if in 2020 (it was a strange year) the continent of Mu had risen from the Pacific Ocean?", "text": "", "author": "death_has_f1sh_eyes", "score": 1572, "num_comments": 233, "date": "2026-03-02", "url": "https://reddit.com/r/AlternateHistoryHub/comments/1rj960q/what_if_in_2020_it_was_a_strange_year_the/", "sentiment": { "label": "negative", "score": -0.202, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "PacificNorthwest", "title": "Found a cool tree tunnel on the Pacific Coast Highway", "text": "", "author": "herpnwadventures-", "score": 6240, "num_comments": 72, "date": "2026-03-18", "url": "https://reddit.com/r/PacificNorthwest/comments/1rx8oex/found_a_cool_tree_tunnel_on_the_pacific_coast/", "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "reddit", "subreddit": "todayilearned", "title": "TIL Under King Kamehameha I, the Kingdom of Hawaii had the largest navy in the entirety of the Pacific", "text": "", "author": "DisconnectedShark", "score": 1493, "num_comments": 230, "date": "2026-03-05", "url": "https://reddit.com/r/todayilearned/comments/1rlrlm1/til_under_king_kamehameha_i_the_kingdom_of_hawaii/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "SantaBarbara", "title": "Motorcycle engine powered drone to cross Asia and the fucking Pacific Ocean to attack us? False flag incoming.", "text": "2027 gonna have Trump did 9/11 2.0 memes 🥀", "author": "Organic_Fee_8502", "score": 963, "num_comments": 387, "date": "2026-03-11", "url": "https://reddit.com/r/SantaBarbara/comments/1rr359x/motorcycle_engine_powered_drone_to_cross_asia_and/", "sentiment": { "label": "negative", "score": -0.477, "confidence": 0.48 } }, { "source": "reddit", "subreddit": "rugbyunion", "title": "A contender for try of the season in Super Rugby Pacific", "text": "", "author": "chickenlittle668", "score": 1659, "num_comments": 183, "date": "2026-02-27", "url": "https://reddit.com/r/rugbyunion/comments/1rg1wgu/a_contender_for_try_of_the_season_in_super_rugby/", "sentiment": { "label": "positive", "score": 0.66, "confidence": 0.66 } }, { "source": "reddit", "subreddit": "Weddingattireapproval", "title": "Cocktail Attire - mixed indoor & outdoor event. Location: Pacific NorthWest", "text": "When: End of June\n\nCeremony is on a mountain. \n\nReception is indoors with outdoor dance floor under canopy.\n\nHeels are very comfortable (block heel & platform). Thinking of adding a statement belt IF the dress works.\n\nI know the bride & groom really well. My husband is a groomsman and will be in a medium blue suit. \n\nI love the dress but happy to get something else if this isnt the vibe. All thoughts welcome, thank you for the help.", "author": "Lovely-Cabbage", "score": 1040, "num_comments": 279, "date": "2026-03-04", "url": "https://reddit.com/r/Weddingattireapproval/comments/1rksrww/cocktail_attire_mixed_indoor_outdoor_event/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "hockey", "title": "The Golden Knights are 28-31 but sit atop of the Pacific Division", "text": "Is it time to get rid of the loser point?", "author": "Icy-Tangelo-8146", "score": 1002, "num_comments": 280, "date": "2026-02-28", "url": "https://reddit.com/r/hockey/comments/1rh3w6h/the_golden_knights_are_2831_but_sit_atop_of_the/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "hockey", "title": "Today was the 7th time in NHL history a division has 6 or more teams playing on a day and none get a win with the Pacific going 0-6. The 6th time it happened was just 2 days ago and it was also the Pacific Division.", "text": "It is absurd how bad the Pacific Division is, every single team that played today from that division lost by multiple goals.", "author": "Ok-Soil-5133", "score": 1408, "num_comments": 160, "date": "2026-03-22", "url": "https://reddit.com/r/hockey/comments/1s0ct5n/today_was_the_7th_time_in_nhl_history_a_division/", "sentiment": { "label": "negative", "score": -0.248, "confidence": 0.25 } } ] } }